RENAKARE- potassium gluconate tablet 
Neogen Corporation-Mercer

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

RenaKare™

Potassium Gluconate Tablets

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

Each tablet contains (minimum):

Potassium gluconate.........2 mEq (468 mg)

Dosage:

Adult cats and dogs...2 mEq/4.5 kg (1 tablet/10 lb) PO BID

Kittens and puppies.............................consult veterinarian

Administer with food. Dosage may be adjusted as necessary by the veterinarian.

Store in a dry place at a temperature between 15°-30°C (59°-86°F). Keep container tightly closed.

Warnings:

May cause hyperkalemia. Do not exceed the recommended dose. Frequent patient monitoring is advised. Adverse effects include gastrointestinal irritation, muscular weakness, twitching, irritability, and cardiac conduction disturbances. Postassium salts are contraindicated in animals with hyperkalemia, severe renal impairment or failure, severe hemolytic reactions, Addison's disease, decreased gastrointestinal motility, and acute dehydration.

Precautions:

Use with caution in animals receiving digoxin, potassium-sparing diuretics, ACE inhibitors, and NSAIDs.

Indications:

For use as a potassium supplement in hypokalemic cats and dogs.

Manufactured by: Neogen Corporation, Lexington, KY 40511

859-254-1221 • neogen.com         L593-1222

Made in the USA of U.S. and imported materials

Item No. 09074

PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle

NDC: 59051-9074-5

RenaKare

Potassium gluconate tablets

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Net Contents: 100 Tablets

RenaKare Tablets

RENAKARE 
potassium gluconate tablet
Product Information
Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:59051-9074
Route of AdministrationOral
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POTASSIUM GLUCONATE (UNII: 12H3K5QKN9) (POTASSIUM CATION - UNII:295O53K152) POTASSIUM GLUCONATE468 mg
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize11mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:59051-9074-5100 in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/15/2013
Labeler - Neogen Corporation-Mercer (042125879)
Establishment
NameAddressID/FEIBusiness Operations
Neogen Corporation-Mercer042125879analysis, label, manufacture
Establishment
NameAddressID/FEIBusiness Operations
Jungbunzlauer Ladenburg GmbH322121609api manufacture

Revised: 2/2023
Document Id: b507079c-b38e-4a58-b713-59e8fe0d8d1f
Set id: 43642434-ed10-49da-954b-a6306cb939de
Version: 5
Effective Time: 20230221
 
Neogen Corporation-Mercer